NL-OMON20300已完成不适用
ew pharmacotherapeutic treatment options for crack-cocaine dependent people in the Netherlands.
Academic Medical Centre, Amsterdam, the Netherlands. Brijder Verslavingszorg (The Hague: 1 study site), BoumanGGZ/Antes (Rotterdam: 1 study site), and GGD Amsterdam (Amsterdam: 2 study sites).0 个研究点目标入组 216 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 216
研究概览
简要总结
- Nuijten, M., Blanken, P., Van de Wetering, B., Nuijen, B., Van den Brink, W., & Hendriks, V. (2016). Sustained- release dexamphetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled, double-blind trial. The Lancet, in press. DOI: http://dx.doi.org/10.1016/S0140-6736(16)00205-1.
2. Nuijten, M., Blanken, P., Van den Brink, W., & Hendriks, V. (2015). Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial. Journal of Psychopharmacology, 29, 678-687.
3. Nuijten, M., Blanken, P., Van den Brink, W., & Hendriks, V. (2014). Treatment of crack-cocaine dependence with topiramate: A randomized controlled feasibility trial in The Netherlands. Drug and Alcohol Dependence, 138, 177-184.
4. Nuijten, M., Blanken, P., Van den Brink, W., & Hendriks, V. (2011). Cocaine Addiction Treatments to improve Control and reduce Harm (CATCH): New Pharmacological Treatment Options for Crack-Cocaine Dependence in the Netherlands. BMC Psychiatry, 11:135.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •In the sub-studies of topiramate and modafinil, eligible patients must:
- •1. Be at least 18 years old;
排除标准
- •Patients will be excluded in case of:
- •1. Severe medical (e.g., severe renal or kidney insufficiency/failure) or psychiatric problems (e.g. acute psychosis, current major depression, suicidal), which constitute a contra-indication for participation;
研究者
相似试验
进行中（未招募）
不适用
ew pharmacotherapeutic treatment options for crack-cocaine dependent people in the Netherlands.EUCTR2009-010584-16-NLZonMw
已完成
2 期
ew pharmacotherapeutic treatment options for crack-cocaine dependent people in the Netherlands: A double-blind, placebo-controlled randomized feasibility study of sustained release dexamphetamineNL-OMON39005Academisch Medisch Centrum72
进行中（未招募）
不适用
ew pharmacologic treatment for crack-cocaine addicts in the Netherlands: A randomized feasibility study comparing sustained release dexamphetamine with placebococaine dependence (according DSM-IV)MedDRA version: 17.0Level: LLTClassification code 10009817Term: Cocaine dependenceSystem Organ Class: 100000004873EUCTR2013-004024-11-NLAcademic Psychiatric Center - AMC-UvA
招募中
1 期
Optimized pharmacologic treatment for broken heart (takotsubo) syndromeTakotsubo syndromeCTIS2022-501874-21-00Vastra Gotalandsregionen1,600
进行中（未招募）
1 期
Optimized pharmacological treatment for broken heart (takotsubo) syndromeThe medical condition is acute heart failure (Takotsubo syndrome)EUCTR2020-002708-38-SEDepartment of Medical Science Gothenburg University1,000